These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29518027)

  • 1. Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract.
    Inoue S; Ide H; Fujita K; Mizushima T; Jiang G; Kawahara T; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
    Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
    Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
    Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uridine 5'diphospho-glucuronosyltransferase 1A expression as an independent prognosticator in urothelial carcinoma of the upper urinary tract.
    Izumi K; Inoue S; Ide H; Fujita K; Mizushima T; Jiang G; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H
    Int J Urol; 2018 May; 25(5):429-435. PubMed ID: 29444544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
    Miyamoto H; Yao JL; Chaux A; Zheng Y; Hsu I; Izumi K; Chang C; Messing EM; Netto GJ; Yeh S
    BJU Int; 2012 Jun; 109(11):1716-26. PubMed ID: 22221549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine.
    Kawahara T; Aljarah AK; Shareef HK; Inoue S; Ide H; Patterson JD; Kashiwagi E; Han B; Li Y; Zheng Y; Miyamoto H
    Prostate; 2016 Jun; 76(8):744-56. PubMed ID: 26864615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.
    Munari E; Fujita K; Faraj S; Chaux A; Gonzalez-Roibon N; Hicks J; Meeker A; Nonomura N; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2668-76. PubMed ID: 24074531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.
    Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF
    Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract.
    Kawahara T; Inoue S; Fujita K; Mizushima T; Ide H; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H
    Transl Oncol; 2017 Jun; 10(3):318-323. PubMed ID: 28327458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
    Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
    Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical determination of ETS-1 oncoprotein expression in urothelial carcinomas of the urinary bladder.
    Sari A; Calli A; Gorgel SN; Altinboga AA; Kara C; Dincel C; Cakalagaoglu F
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):153-8. PubMed ID: 21623185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract.
    Kashiwagi E; Fujita K; Yamaguchi S; Fushimi H; Ide H; Inoue S; Mizushima T; Reis LO; Sharma R; Netto GJ; Nonomura N; Miyamoto H
    Cancer Biol Ther; 2016 Nov; 17(11):1188-1196. PubMed ID: 27635763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forkhead box O1 as an indicator of prognosis is inactivated in urothelial carcinoma of the upper urinary tract.
    Ide H; Jiang G; Mizushima T; Fujita K; Inoue S; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H
    Oncol Lett; 2019 Jan; 17(1):482-487. PubMed ID: 30655790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
    Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
    J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion.
    Kosaka T; Kikuchi E; Mikami S; Miyajima A; Shirotake S; Ishida M; Okada Y; Oya M
    Clin Cancer Res; 2010 Dec; 16(23):5814-23. PubMed ID: 20947514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor.
    Miyamoto H; Izumi K; Yao JL; Li Y; Yang Q; McMahon LA; Gonzalez-Roibon N; Hicks DG; Tacha D; Netto GJ
    Hum Pathol; 2012 Nov; 43(11):2033-40. PubMed ID: 22607700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of human epidermal growth factor receptor 2 status in urothelial carcinoma of the upper urinary tract: a study using dual-color in situ hybridization and immunohistochemistry.
    Vershasselt-Crinquette M; Colin P; Ouzzane A; Gnemmi V; Robin YM; Aubert S; Villers A; Leroy X
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):363-6. PubMed ID: 22495372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
    Go H; Kim PJ; Jeon YK; Cho YM; Kim K; Park BH; Ku JY
    Eur J Cancer; 2015 Sep; 51(14):1937-45. PubMed ID: 26238015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer.
    Hupe MC; Dormayer L; Ozimek T; Struck JP; Hennig MJP; Klee M; von Klot CAJ; Kuczyk MA; Merseburger AS; Kramer MW
    BMC Cancer; 2020 Feb; 20(1):140. PubMed ID: 32085750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.